Betmiga 50mg Tablet
Marketer
Astellas Pharma Inc
Salt Composition
Mirabegron (50mg)
Overview Betmiga 50mg Tablet
Mirabegron 50mg tablets alleviate overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes the bladder muscle, improving its urine storage capacity. Always adhere to your doctor's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinue use only after consulting your physician, as abrupt cessation may exacerbate symptoms. Completing the prescribed course ensures optimal therapeutic effect. Possible side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects promptly to your doctor. Before starting treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their physician.
Uses of Betmiga 50mg Tablet
Managing overactive bladder (OAB)
Major Benefits of Betmiga 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Betmiga 50mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Betmiga 50mg Tablet:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Betmiga 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Betmiga 50mg tablets can be administered with or without food, though consistent timing is recommended.
How Betmiga 50mg Tablet works:
Betmiga 50mg tablets utilize a beta-3 adrenergic agonist mechanism. This activates bladder receptors, promoting relaxation of the bladder's musculature and thus reducing urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use of Betmiga 50mg Tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Betmiga 50mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Betmiga 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Betmiga 50mg tablets.
KidneyCAUTION
Individuals with severe kidney impairment should use Mirabegron 50mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Betmiga 50mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Betmiga 50mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Betmiga 50mg Tablet :
For a missed Betmiga 50mg Tablet, take it promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Betmiga 50mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Actions | Selective beta-3 agonist for bladder function |
3,018 People bought this recently